ZNF582 methylation is another confirmed marker associated with cervical cancer (Li et al., 2019), and ZNF582 methylation has also been reported as a potential marker for EC detection in tissue samples (Tang et al., 2019), although the study of ZNF582 methylation in plasma samples is insufficient. This evidence concerns the gene ZNF582 and cervical cancer.